UP780, a Chromone-Enriched Aloe Composition, Enhances Adipose Insulin Receptor Signaling and Decreases Liver Lipid Biosynthesis

Julie Tseng-Crank, Seon-Gil Do, Brandon Corneliusen, Carmen Hertel, Jennifer Homan, Mesfin Yimam, Jifu Zhao, Qi Jia

Unigen Korea, Songjung-Ri, Byeongchen-Myeon, Vheonan-Si, Chungnam, South Korea.
Unigen, Seattle, USA.

DOI: 10.4236/ojgen.2013.32A2002                

Abstract

Nutrigenomic studies were conducted to uncover the mechanism of action for the hypoglycemic and insulin sensitizing effects of UP780. From high fat diet-induced obesity mouse model for UP780, livers and white adipose tissues (WAT) from groups of lean control, high fat diet (HFD), and HFD treated with UP780 were collected for microarray study. Microarray generated gene expression changes were applied to Ingenuity Pathway Analysis for changes in canonical metabolic and signaling pathways. Microarray was validated by quantitative reverse transcriptase-polymerase chain reaction (QPCR), Western blots, liver triglyceride, liver cholesterol, liver steatosis, and insulin ELISA. UP780 treatment decreased liver gene expressions for multiple enzymes involved in fatty acid biosynthesis and triglyceride production. UP780 treatment increased gene expressions globally for the insulin receptor signaling pathway in WAT. Both liver triglyceride and liver cholesterol levels were significantly reduced by UP780 over HFD. The reduction of liver fat was confirmed by microscopic analysis of liver steatosis. Finally, UP780 significantly decreased fasting plasma insulin level over HFD. The mechanism of action for UP780 indicated a reduction of liver fat accumulation and an enhancement in adipose tissue insulin signaling pathway. This provided mechanistic explanation for the in vivo UP780 effects of enhanced insulin sensitiveity and decreased blood glucose in mouse diabetes and prediabetes models.

Keywords

Nutrigenomics; Insulin Signaling Pathway; Liver Fatty Acid Biosynthesis; Liver Steatosis; Aloe Vera

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	CDC (2011) National diabetes factsheet. http://www.cdc.gov/diabetes/pubs/factsheet11.htm
[2]	WHO (2011) Diabetes: Fact sheet. http://www.who.int/mediacentre/factsheets/fs312/en/index.html
[3]	Reaven, G.M. (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-1607. doi:10.2337/diabetes.37.12.1595
[4]	Kahn, S.E., Hull, R.L. and Utzschneider, K.M. (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444, 840-846. doi:10.1038/nature05482
[5]	Kim, K., Kim, H., Kwon, J., Lee, S., Kong, H., Im, S.A., Lee, Y.H., Lee, Y.R., Oh, S.T., Jo, T.H., Park, Y.I. and Lee, C.K. (2009) Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine, 16, 856-863. doi:10.1016/j.phymed.2009.02.014
[6]	Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., Li, X., Ning, G. and Zhao, L. (2012) Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One, 7, e42529. doi:10.1371/journal.pone.0042529
[7]	Zhao, H.L, Sui, Y., Qiao, C.F., Yip, K.Y., Leung, R.K., Tsui, S.K., Lee, H.M., Wong, H.K., Zhu, X., Siu, J.J., He, L., Guan, J., Liu, L.Z., Xu, H.X., Tong, P.C. and Chan, J.C. (2012) Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression. Diabetes, 61, 933-943. doi:10.2337/db11-1164
[8]	Chen, Q., Chan, L.L. and Li, E.T. (2003) Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. Journal of Nutrition, 133, 1088-1093.
[9]	Xiong, Y., Shen, L., Liu, K.J., Tso, P., Wang, G., Woods, S.C. and Liu, M. (2010) Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes, 59, 2505-2512. doi:10.2337/db10-0315
[10]	Liu, D., Zhen, W., Yang, Z., Carter, J.D., Si, H. and Reynolds, K.A. (2006) Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway. Diabetes, 55, 1043-1050. doi:10.2337/diabetes.55.04.06.db05-1089
[11]	Dugoua, J.J., Seely, D., Perri, D., Cooley, K., Forelli, T., Mills, E. and Koren, G. (2007) From type 2 diabetes to antioxidant activity: A systematic review of the safety and efficacy of common and cassia cinnamon bark. Canadian Journal of Physiology and Pharmacology, 85, 837-847. doi:10.1139/Y07-080
[12]	Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A, Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Le Couteur, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., de Cabo, R. and Sinclair, D.A. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342. doi:10.1038/nature05354
[13]	Ajabnoor, M.A. (1990) Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. Journal of Ethnopharmacology, 28, 215-220. doi:10.1016/0378-8741(90)90031-N
[14]	Ghannam, N., Kingston, M., Al-Meshaal, I.A., Tariq, M., Parman, N.S. and Woodhouse, N. (1986) The antidiabetic activity of aloes: Preliminary clinical and experimental observations. Hormone Research, 24, 288-294. doi:10.1159/000180569
[15]	Chacko, S., Sabatha, T. and Kuttan, R. (2008) Amelioration of alloxan-induced hyperglycemia by Aloe arborescens Miller and its possible mechanism. Pharmacologyonline, 2, 112-125.
[16]	Can, A., Akev, N., Ozsoy, N., Bolkent, S., Arda, B.P., Yanardag, R. and Okyar, A. (2004) Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biological & Pharmaceutical Bulletin, 27, 694-698. doi:10.1248/bpb.27.694
[17]	Rajasekaran, S., Sivagnanam, K., Ravi, K. and Subramanian, S. (2004) Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. Journal of Medicinal Food, 7, 61-66. doi:10.1089/109662004322984725
[18]	Yimam, M., Zhao, J., Corneliusen, B., Pantier, M., Brownell, L. and Jia, Q. (2013) UP780, a chromone enriched Aloe composition, improves insulin sensitivity. Metabolic Syndrome and Related Disorders, 10, 319-386. doi:10.1089/met.2012.0135
[19]	Devaraj, S., Yimam, M., Brownell, L., Jialal, I., Singh, S. and Jia, Q. (2012) Effects of aloe vera supplementation in subjects with pre-diabetes/metabolic syndrome. Metabolic Syndrome and Related Disorders, 10, 319-386.
[20]	Rajasekaran, S., Ravi, K., Sivagnanam, K. and Subramanian, S. (2006) Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clinical and Experimental Pharmacology and Physiology, 33, 232-237. doi:10.1111/j.1440-1681.2006.04351.x
[21]	Tanaka, M., Misawa, E., Ito, Y., Habara, N., Nomaguchi, K., Yamada, M., Toida, T., Hayasawa, H., Takase, M., Inagaki, M. and Higuchi, R. (2006) Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biological & Pharmaceutical Bulletin, 29, 1418-1422. doi:10.1248/bpb.29.1418
[22]	Hamman, J.H. (2008) Composition and applications of Aloe vera leaf gel. Molecules, 13, 1599-1616. doi:10.3390/molecules13081599
[23]	Berger, J. and Moller, D.E. (2002) The mechanisms of action of PPARs. Annual Review of Medicine, 53, 409-435. doi:10.1146/annurev.med.53.082901.104018
[24]	OMIM’: Online mendelian inheritance in Man®. http://omim.org/
[25]	Ingenuity pathway analysis. http://www.ingenuity.com/
[26]	Shulman, G.I. (2004) Unraveling the cellular mechanism of insulin resistance in humans: New insights from magnetic resonance spectroscopy. Physiology (Bethesda), 19, 183-190. doi:10.1152/physiol.00007.2004
[27]	Le Gouill, E., Jimenez, M., Binnert, C., Jayet, P.Y., Thalmann, S., Nicod, P., Scherrer, U. and Vollenweider, P. (2007) Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation. Diabetes, 56, 2690-2696. doi:10.2337/db06-1228
[28]	Saltiel, A.R. and Kahn, C.R. (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414, 799-806. doi:10.1038/414799a
[29]	Powell, K. (2007) Obesity: The two faces of fat. Nature, 447, 525-527. doi:10.1038/447525a
[30]	Anderson, N. and Borlak, J. (2008) Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacological Reviews, 60, 311-357. doi:10.1124/pr.108.00001
[31]	Kadowaki, T. and Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocrine Reviews, 26, 439-451. doi:10.1210/er.2005-0005
[32]	Hardie, D.G. (2004) The AMP-activated protein kinase pathway—New players upstream and downstream. Journal of Cell Science, 117, 5479-5487. doi:10.1242/jcs.01540
[33]	Holland, W.L., Miller, R.A., Wang, Z.V., Sun, K., Barth, B.M., Bui, H.H., Davis, K.E., Bikman, B.T., Halberg, N., Rutkowski, J.M., Wade, M.R., Tenorio, V.M., Kuo, M.S, Brozinick, J.T., Zhang, B.B., Birnbaum, M.J., Summers, S.A. and Scherer, P.E. (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature Medicine, 17, 55-63. doi:10.1038/nm.2277
[34]	Shin, E., Shin, S., Kong, H., Lee, S., Do, S.G., Jo, T.H., Park, Y.I., Lee, C.K., Hwang, I.K. and Kim, K. (2011) Dietary aloe reduces adipogenesis via the activation of AMPK and suppresses obesity-related inflammation in obese mice. Immune Netw, 11, 107-113. doi:10.4110/in.2011.11.2.107
[35]	Ngo, M.Q., Nguyen, N.N. and Shah, S.A. (2010) Oral aloe vera for treatment of diabetes mellitus and dyslipidemia. American Journal of Health-System Pharmacy, 67, 1804-1808.
[36]	Yongchaiyudha, S., Rungpitarangsi, V., Bunyapraphatsara, N. and Chokechaijaroenporn, O. (1996) Antidiabetic activity of aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine, 3, 241-243. doi:10.1016/S0944-7113(96)80060-2
[37]	Bunyapraphatsara, N., Yongchaiyudha, S., Rungpitarangsi, V. and Chokechaijaroenporn, O. (1996) Antidiabetic activity of Aloe vera L. juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine, 3, 245-248. doi:10.1016/S0944-7113(96)80061-4
[38]	Huseini, H.F., Kianbakht, S., Hajiaghaee, R. and Dabaghian, F.H. (2011) Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: A randomized doubleblind placebo-controlled clinical trial. Planta Medica, 78, 311-316. doi:10.1055/s-0031-1280474
[39]	Yagi, A., Hegazy, S., Kabbash, A. and Abd-El Wahab, E. (2009) Possible hypoglycemic effect of aloe vera L. high molecular weight fractions on type 2 diabetic patients. Saudi Pharmaceutical Journal, 17, 209-215. doi:10.1016/j.jsps.2009.08.007